CANNABIS
Synthetic cannabinoid nabilone significantly improves fibromyalgia pain over 1 week
J Pain. 2008 Feb;9(2):164-73. http://dx.doi.org/10.1016/j.jpain.2007.09.00240 patients with fibromyalgia and chronic pain were randomized to receive increasing doses of nabilone or placebo. The purpose of the study was to determine whether nabilone significantly improved pain, fibromyalgia impact questionnaire (FIQ) scores, number and pain threshold of tender points over 4 weeks. Results indicated that weaker doses were not significantly effective, but nabilone 1 mg BID significantly improved VAS, FIQ and FIQ anxiety scale scores compared to baseline and placebo. Nabilone was associated with significantly more adverse effects. A total of 5 patients from the nabilone group and 2 placebo patients withdrew from the study.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
